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AbstrACt
Objectives To study systematic errors in recording blood 
pressure (BP) as measured by end digit preference (EDP); to 
determine associations between EDP, uptake of Automated 
Office BP (AOBP) machines and cardiovascular outcomes.
Design Retrospective observational study using routinely 
collected electronic medical record data from 2006 to 
2015 and a survey on year of AOBP acquisition in Toronto, 
Canada in 2017.
setting Primary care practices in Canada and the UK.
Participants Adults aged 18 years or more.
Main outcome measures Mean rates of EDP and change 
in rates. Rates of EDP following acquisition of an AOBP 
machine. Associations between site EDP levels and mean 
BP. Associations between site EDP levels and frequency of 
cardiovascular outcomes.
results 707 227 patients in Canada and 1 558 471 patients 
in the UK were included. From 2006 to 2015, the mean rate of 
BP readings with both systolic and diastolic pressure ending 
in zero decreased from 26.6% to 15.4% in Canada and from 
24.2% to 17.3% in the UK. Systolic BP readings ending in 
zero decreased from 41.8% to 32.5% in the 3 years following 
the purchase of an AOBP machine. Sites with high EDP had 
a mean systolic BP of 2.0 mm Hg in Canada, and 1.7 mm Hg 
in the UK, lower than sites with no or low EDP. Patients in 
sites with high levels of EDP had a higher frequency of stroke 
(standardised morbidity ratio (SMR) 1.15, 95% CI 1.12 to 
1.17), myocardial infarction (SMR 1.16, 95% CI 1.14 to 1.19) 
and angina (SMR 1.25, 95% CI 1.22 to 1.28) than patients in 
sites with no or low EDP.
Conclusions Acquisition of an AOBP machine was 
associated with a decrease in EDP levels. Sites with higher 
rates of EDP had lower mean BPs and a higher frequency of 
adverse cardiovascular outcomes. The routine use of manual 
office-based BP measurement should be reconsidered.
IntrODuCtIOn 
High blood pressure (BP) is a leading cause 
of increased morbidity and early mortality in 
adults.1 BP should be routinely measured as 
part of clinical encounters.2 However, there 
are long-standing concerns about the preci-
sion and accuracy of BP measurement in 
practice.3 4 There is evidence that measuring 
BP manually, using an aneroid or mercury 
column sphygmomanometer, is associated 
with systematic recording errors including 
end digit preference (EDP) and observer 
bias.5 EDP means that the observer rounds 
off the last digit6; for example, BPs end in 
zero for up to 60% of records instead of 
the expected 10%.7 8 Observer bias means 
that BP is adjusted towards a preferred level 
(rounding up or rounding down).8 These 
issues may lead to errors in the diagnosis and 
treatment of hypertension.9 
Automated Office BP (AOBP) measure-
ment uses a machine to record and report 
the numerical values of systolic and diastolic 
BPs on a digital display.10 Three to six record-
ings are done; the initial reading is discarded 
and the remaining readings are averaged.11 
Research suggests that EDP is reduced as 
a result of this method.9 11 AOBP is compa-
rable to the gold standard of 24 hours 
strengths and limitations of this study
 ► The study found that the purchase of Automated 
Office BP (AOBP) machines by primary care offices 
was followed by more accurate blood pressure (BP) 
measurement.
 ► Offices with less accurate BP measurement (more 
end digit preference) rounded BP readings down.
 ► These offices also had higher frequencies of adverse 
cardiovascular outcomes.
 ► The survey of AOBP machine purchase was done 
only in Ontario; we infer that the purchase of an 
AOBP machine was associated with less end digit 
preference elsewhere.
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automated home BP monitoring.12 Canadian and Euro-
pean hypertension guidelines now recommend AOBP as 
the preferred method for office-based measurement of 
BP,2 13 but have not made a recommendation to discon-
tinue the routine use of manual BP measurement.
There is evidence that AOBP machines are increasingly 
used in primary care; it has been reported that >10 000 
AOBP machines are currently in use in Canada.11 In a 
recent Canadian survey, 43% of family physicians reported 
using AOBP to screen for hypertension.14 However, the 
proportion of office BP measurements done using AOBP 
when machines are available in an office is not known. 
Changes in the proportion of BPs with EDP could serve 
as a marker of increasing use of AOBP in primary care 
practice, although this requires validation.
Accurate measurement is essential for BP control. 
There is a need to quantify systematic BP measurement 
errors in primary care, consider these in the context of 
changing AOBP use and estimate the effects of errors on 
cardiovascular outcomes affected by BP control.
The objectives of this study were therefore to (1) report 
the EDP levels with respect to patient-level and provid-
er-level characteristics, (2) examine the changes in EDP 
with AOBP uptake in offices, (3) quantify prevalence and 
trends in systematic recording errors in BP recording and 
(4) determine associations between EDP and cardiovas-
cular outcomes.
MethODs
We used a repeated cross-sectional observational design. 
We applied the STrengthening the Reporting of OBser-
vational studies in Epidemiology checklist for reporting 
observational studies.15
settings and data sources
Canada
The Canadian Primary Care Sentinel Surveillance Network 
(CPCSSN) database was used for this study.16 CPCSSN is 
Canada's largest electronic medical record (EMR)-based 
chronic disease surveillance system16 and includes data 
collected from 11 primary care practice-based research 
networks in 8 of Canada’s 13 provinces and territories. 
Consenting family physicians and other primary care 
providers participating in CPCSSN contribute de-identi-
fied EMR data to regional network repositories; patients 
can opt-out if they choose to do so. Data from all partici-
pating networks are collected every 6 months and aggre-
gated in a single central database.16 The distribution of 
the CPCSSN patient population is reasonably similar to 
that of Canadian census.17
We used EMR data extracted and processed using 
procedures previously described.16 CPCSSN case defini-
tion algorithms have been validated against chart audits 
for eight chronic conditions (diabetes, hypertension, 
chronic obstructive pulmonary disease, depression, 
osteoarthritis, dementia, parkinsonism and epilepsy) in 
multiple sites across Canada.18
UK
We repeated the analyses using the Royal College of 
General Practitioners (RCGP) Research and Surveil-
lance Centre (RSC) database for the UK. This is one of 
Europe’s oldest primary care sentinel networks.6 It has 
been reported that the RCGP RSC has data of high quality 
for chronic disease, including diabetes6 and cardiovas-
cular outcomes.19
The RCGP RSC data are extracted twice weekly from the 
EMRs of >150 representative general practices (groups of 
physicians practising in the same location) in England, 
covering a population of over 1.5 million patients and 
3% of the population. A comparison of RCGP RSC prac-
tices with national pay-for-performance data, prescribing 
data and the quality and outcomes framework suggests 
that data are representative of the national population 
in terms of age and gender of the population, ethnicity 
and deprivation.6 RCGP RSC includes comprehensive 
recording of cardiovascular risk factors and outcomes.20
study population
We used routinely collected clinical EMR data from 
primary care clinics across Canada and the UK. These data 
were extracted in Canada as of 30 June 2016 and in the 
UK as of 31 December 2016. We examined BP measure-
ments taken between 1 January 2006 and 31 December 
2015 in the CPCSSN database and in the RCGP RSC data-
base. We included all patients who were at least 18 years 
of age as of BP measurement date. We identified patient 
characteristics that may influence BP and its measure-
ment. Patient variables included: age, sex, presence of 
hypertension and/or diabetes, body mass index (BMI), 
use of hypertensive medications. We recorded the total 
number of patients included for each site; a site was a 
group of physicians practising in the same location.
statistical analysis
We examined the proportions of BPs ending in each 
digit in Canada and UK. We used the entire collection 
of BP records in both databases to estimate the unad-
justed frequency of last digit zero for both systolic and 
diastolic BPs with respect to patient, site and temporal 
characteristics.
Since many patients had BP recorded multiple times 
with irregular visit to primary care between January 
2006 and December 2015, we chose to discard excess 
information using a sampling mechanism.21 In partic-
ular, we generated 1000 independent replicates using 
the stratified sampling without replacement where 
one BP measurement was randomly chosen for a given 
patient. Logistic regression was performed on 1000 inde-
pendently sampled replicates of the CPCSSN and RCGP 
RSC database. The ORs were estimated using the mean 
and 95% CIs were estimated using the 2.5% and 97.5% 
percentiles of 1000 bootstrap estimates.22 All covariates in 
the regression model were held constant to their latest 
value for each patient with respect to the study follow-up. 
For example, the most recent information on BMI or 
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the diagnosis of diabetes or hypertension medication 
was used for each patient. We adjusted for patient vari-
ables that may influence BP or its measurement: age, sex, 
presence of hypertension and/or diabetes, BMI, use of 
hypertensive medications. We also adjusted for the size of 
the practice panels, as this may influence quality of care. 
Finally, we adjusted for year of measurement as EDP levels 
changed over time.
To correlate rates of EDP with AOBP uptake, we 
conducted a subgroup analysis using data from 
the University of Toronto Practice-Based Research 
Network (UTOPIAN). UTOPIAN is the largest network 
in CPCSSN, with about 25% of data in the national data-
base; it includes providers and patients from Toronto 
and surrounding areas in southern Ontario, Canada. We 
collected data on AOBP use from UTOPIAN practices 
using a survey, shown in online supplementary mate-
rial. We contacted office representatives through email/
phone and asked them whether there was an AOBP in the 
office and when it was purchased. Office representatives 
were also asked to estimate how often BPs were done with 
the machine in the past year.
Responses were linked with EMR-based BP measure-
ments for each site and the linked data were used for the 
subgroup analysis. We examined the association between 
length of time the machine was present in the office and 
the rate of EDP, as well as association between EDP for 
2015 and the self-reported level of use in the past year.
We implemented unsupervised cluster analysis to cate-
gorise primary care sites into three groups for each year.23 
The three groups were labelled as: (1) high EDP, (2) 
medium EDP and (3) low or no EDP. Practices were clus-
tered by presence of less commonly recorded end digits 
(1, 3, 7, 9) for both systolic  BP and diastolic BP; 40% 
of BPs would be expected to end in one of those digits. 
To control for excessive noise in the data, we chose to 
exclude the sites with <1000 BP measurements within a 
year.
Since the changes in uncommon end digits (1, 3, 7, 9) 
may be confounded by the recruitment of new sites over 
time or changes in patient populations within sites, the 
proportion of recording uncommon digits was reported 
for each measurement year, giving a rate of EDP per site 
per year. The similarity between all pairs belonging to the 
same cluster was computed using the Ward score.24 We 
examined the mean systolic BP among patients with and 
without hypertension and diabetes using the classification 
obtained from the cluster analysis.
We estimated the annual frequency of three cardio-
vascular events (myocardial infarction, angina, stroke) 
using UK data; these conditions have not yet been vali-
dated in the Canadian data in CPCSSN. We compared 
sites with high EDP in each year against sites with low or 
no EDP for the same year. The denominator was defined 
as the total number of patients who had at least one BP 
recorded within each year of interest for each group. The 
numerator was defined as the total number of patients 
included in the denominator with a cardiovascular event 
within the same year. Patients with a cardiovascular event 
were censored in subsequent years. We estimated the 
standardised morbidity ratio for each condition in groups 
with high EDP compared with groups with low or no EDP.
The study received a favourable opinion from the 
RCGP RSC study review panel. CPCSSN has received REB 
approval from Health Canada, and each host university 
for all participating practice-based research networks. 
All participating primary care providers have provided 
written informed consent for the collection and analysis 
of their EMR data. All statistical analyses were conducted 
using SAS software, V.9.4 M4 (SAS Institute).
Patient and public involvement
No patients were involved in setting the research ques-
tion or the outcome measures, nor were they involved 
in developing plans for design or implementation of the 
study. We received input into the study from patient and 
public representatives who commented on the relevance 
of the question and the potential impact of the research 
on outcomes.
results
Data from 181 sites and 707 227 patients in CPCSSN were 
included; there were 5.5 million BP records. Data from 
164 sites and 1 558 471 patients in the RCGP RSC data-
base were included; there were 13.4 million BP records. 
Each patient was counted once, regardless of the number 
of BPs and number of years in which they had a BP 
recorded. The most frequently recorded end digit was 
zero while the least frequent end digits were 1, 3, 7 and 9 
(table 1, figure 1).
Patient and site characteristics and trends in levels of 
EDP are shown in table 2. The frequency of last digit zero 
for both systolic and diastolic BP decreased by 11.2% in 
Canada and by 6.9% in the UK from 2006 to 2015. Table 3 
describes the adjusted ORs of recording zero as the last 
digit of systolic and diastolic BP. The ORs of last digit zero 
Table 1 Frequency of end digits for systolic and diastolic 
blood pressures
End digits
Canada UK
Systolic 
BP (%)
Diastolic 
BP (%)
Systolic 
BP (%)
Diastolic 
BP (%)
0 32.4 35.9 33.8 34.0
1 3.6 3.7 4.5 4.5
2 13.1 10.9 10.3 9.6
3 3.8 3.8 4.8 4.7
4 10.4 10.0 9.1 9.3
5 7.2 6.8 8.3 8.2
6 9.3 8.9 8.5 8.4
7 3.9 3.8 4.9 4.8
8 12.6 12.4 11.2 11.6
9 3.8 3.4 4.8 4.9
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were greater among female patients (CPCSSN: OR=1.10, 
95% CI 1.09 to 1.11; RCGP: OR=1.16, 95% CI 1.15 to 1.16). 
Patients with hypertension were less likely to have EDP 
than patients without hypertension (CPCSSN: OR=0.89, 
95% CI 0.88 to 0.91; RCGP RSC: OR=0.79, 95% CI 0.78 to 
0.80). Patients with diabetes were less likely to have EDP 
in Canada (OR=0.98, 95% CI 0.96 to 0.99) but were more 
likely to have this in the UK (OR=1.025, 95% CI 1.01 to 
1.04). ORs of EDP decreased as BMI levels increased in 
Canada but not in the UK.
Sixty-five UTOPIAN sites were surveyed; 55 (85%) 
responded. Ninety-three per cent of the UTOPIAN sites 
reported having at least one AOBP machine in the prac-
tice; most were bought between 2007 and 2014. Even 
when AOBP machines were present, most offices reported 
still using manual measurement. There was a reduction 
of 9.3% (from 41.7% to 32.5%) in the proportion of 
systolic BPs ending in zero within 3 years of adopting the 
AOBP machines (95% CI −8.9% to −9.8%). Family prac-
tices who reported rarely or never using AOBP machines 
had higher EDP than those reporting at least some use of 
AOBP (figure 2).
As illustrated in figure 3, cluster analyses were used to 
find the optimal decision boundaries to classify sites into 
high EDP, medium EDP, low or no EDP for Canada and 
the UK. Table 4 provides the number and percentage of 
sites in each group. In 2006, there was only one Canadian 
site (3.6%) with low or no EDP while in the UK, 61 sites 
(38.4%) were in this group. Sites exhibiting high EDP 
decreased by 47.7% in Canada and by 15.1% in the UK 
from 2006 to 2015. In contrast, the proportion of sites 
classified as having low or no EDP increased by 22.9% in 
Canada and 12.8% in the UK.
The mean systolic BP by EDP group is shown in table 5. 
Sites with low or no EDP had a higher mean systolic 
BP than sites with high EDP (1.97 mm Hg in Canada; 
1.76 mm Hg in the UK). When stratified by presence or 
absence of hypertension or diabetes, the direction was 
similar with differences ranging from 0.9 to 2.4 mm Hg.
As shown in figure 4, we observed a higher mean 
frequency of myocardial infarction (0.40%, 95% CI 0.39 
to 0.41), stroke (0.64%, 95% CI 0.63 to 0.65) and angina 
(0.42%, 95% CI 0.41 to 0.43) in sites with high EDP as 
compared with sites with low or no EDP: 0.34% (95% CI 
0.33 to 0.35), 0.56% (95% CI 0.55 to 0.57) and 0.33% 
(95% CI 0.32 to 0.34), respectively. Table 6 provides the 
standardised morbidity ratio; this was higher for all three 
conditions for sites with high EDP compared with sites 
with low or no EDP.
DIsCussIOn
We found significant levels of systematic recording 
errors in BP measurement in the UK and Canada; these 
decreased over time. There was an association between 
the length of time an AOBP machine was present in an 
office and a decrease in EDP. Higher rates of EDP, and 
presumably more use of manual BP recording in those 
sites, appeared to be associated with rounding down of 
BPs and a higher frequency of adverse cardiovascular 
outcomes.
Our study found decreasing rates of in EDP; there 
have been increasingly strong guideline recommenda-
tions to switch to AOBP.2 25 While a recent survey found 
that almost half of Canadian physicians reported using 
AOBP to screen for hypertension,14 most offices in this 
study reported continued use of manual BP measure-
ment for some patients even when an AOBP machine 
was present in the office. We found a gradual decrease 
in EDP associated with the length of time that AOBP has 
been present in the office, indicating that physicians and 
sites may be increasingly accustomed to its routine use for 
measurement.
European Guidelines recommending adoption of 
AOBP were associated with a large decrease in recorded 
BPs ending in zero in the UK, from 71.2% in 1996–1997 
to 36.7% in 2005–2006.26 UK studies based on the Quality 
Improvement in Chronic Kidney Disease trial27 have 
Figure 1 Histogram of systolic (sBP) and diastolic blood pressure (dBP) in Canada and the UK.
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Table 2 Patient/site characteristics and BP measurements ending in zero for both systolic BP and diastolic BP in Canada 
(CPCSSN) and the UK (RCGP RSC database)
Characteristics
Canada UK
Number of patients 
(% of patients)
Number of BPs (% 
of BPs)
Number of BPs 
with both systolic 
and diastolic BP 
ending in zero (% 
with both ending 
in zero)
Number of patients 
(% of patients)
Number of BPs (% 
of BPs)
Number of BPs 
with both systolic 
and diastolic BP 
ending in zero (% 
with both ending 
in zero)
Total 707 227 5 503 663 1 044 031 (19.0%) 1 558 471 13 424 678 2 674 497 (19.9%) 
Age (years) 
  18–39 189 254 (26.8) 816 136 (14.8) 165 025 (20.2) 531 632 (34.1) 2 330 344 (17.4) 538 786 (23.1)
  40–59 247 771 (35) 1 534 126 (27.9) 292 435 (19.1) 498 272 (32.0) 3 298 174 (24.6) 631 260 (19.1)
  60–79 201 364 (28.5) 2 115 655 (38.4) 377 724 (17.9) 352 483 (22.6) 4 879 583 (36.3) 868 894 (17.8)
  80+ 68 838 (9.7) 1 037 716 (18.9) 208 847 (20.1) 176 084 (11.3) 2 916 577 (21.7) 635 557 (21.8)
Sex
  Female 414 644 (58.6) 3 325 256 (60.4) 648 357 (19.5) 901 866 (57.9) 8 133 678 (60.6) 1 708 742 (21.0)
  Male 292 583 (41.4) 2 178 377 (39.6) 395 674 (18.2) 656 605 (42.13) 5 291 000 (39.4) 965 755 (18.3)
BMI range
  Underweight 
(BMI<18.5)
10 233 (1.4) 70 776 (1.3) 14 649 (20.7) 44 654 (2.9) 308 481 (2.3) 71 234 (23.1)
  Normal weight 
(18.5–24.9)
170 684 (24.1) 1 177 970 (21.4) 236 883 (20.1) 560 214 (36.0) 4 071 114 (30.3) 852 192 (20.9)
  Overweight 
(25–29.9)
182 141 (25.8) 1 545 777 (28.1) 283 163 (18.3) 446 850 (28.7) 4 412 326 (32.9) 842 338 (19.1)
  Obesity class I 
(30–34.9)
101 980 (14.4) 1 013 286 (18.4) 175 781 (17.3) 200 761 (12.9) 2 421 241 (18.0) 455 572 (18.8)
  Obesity class II 
(35–39.9)
42 235 (6.0) 468 239 (8.5) 77 408 (16.5) 71 450 (4.6) 928 259 (6.9) 176 969 (19.1)
  Obesity class III 
(>40)
27 451 (3.9) 320 682 (5.8) 52 327 (16.3) 37 370 (2.4) 491 533 (3.7) 96 589 (19.7)
  Not available 172 503 (24.4) 906 903 (16.5) 203 820 (22.5) 197 172 (12.7) 791 724 (5.9) 179 603 (22.7)
Diabetes
  Yes 86 103 (12.2) 1 299 693 (23.6) 233 944 (18) 65 335 (4.2) 1 909 804 (14.2) 359 324 (18.8)
  No 621 124 (87.8) 4 203 940 (76.4) 810 087 (19.3) 1 493 136 (95.1) 11 514 874 (85.8) 2 315 173 (20.1)
Hypertension
  Yes 185 508 (26.2) 2 704 921 (49.1) 486 787 (18) 235 716 (15.1) 6 359 131 (47.4) 1 141 665 (18.0)
  No 521 719 (73.8) 2 798 712 (50.9) 557 244 (19.9) 1 322 755 (84.9) 7 065 547 (52.6) 1 532 832 (21.7)
Hypertension 
medications
  Yes 125 484 (17.7) 2 704 947 (49.1) 395 371 (17.7) 466 800 (30.0) 8 327 009 (62.0) 1 571 464 (18.9)
  No 581 743 (82.3) 2 798 686 (50.9) 648 660 (19.8) 1 091 671 (70.1) 5 097 669 (38.0) 1 103 033 (21.6)
Practice site size
  First quartile 
(smallest site)
36 363 (5.1) 249 957 (4.5) 63 781 (25.5) 173 610 (11.1) 1 671 387 (12.5) 303 084 (18.1)
  Second quartile 77 776 (11) 584 575 (10.6) 110 411 (18.9) 305 460 (19.6) 2 836 288 (21.1) 480 604 (16.9)
  Third quartile 156 601 (22.1) 1 156 892 (21.0) 228 521 (19.8) 416 580 (26.7) 3 774 278 (28.1) 846 481 (22.4)
  Fourth quartile 
(largest site)
436 487 (61.7) 3 512 209 (63.8) 641 318 (18.3) 662 821 (42.5) 5 142 725 (38.3) 1 044 328 (20.3)
Measurement year*
  2006 52 168 (7.4) 121 355 (2.2) 32 335 (26.6) 542 695 (34.8) 1 347 400 (10.0) 325 843 (24.2)
  2007 81 699 (11.6) 183 591 (3.3) 49 030 (26.7) 553 033 (35.5) 1 342 979 (10.1) 303 477 (22.6)
  2008 125 781 (17.8) 277 858 (5.0) 72 772 (26.2) 563 222 (36.1) 1 353 092 (10.1) 288 418 (21.3)
  2009 167 345 (23.7) 368 245 (6.7) 94 871 (25.8) 572 940 (36.8) 1 358 664 (10.1) 278 829 (20.5)
  2010 213 250 (30.2) 531 316 (9.7) 117 612 (22.1) 580 069 (37.2) 1 340 279 (10.0) 266 242 (19.9)
Continued
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Characteristics
Canada UK
Number of patients 
(% of patients)
Number of BPs (% 
of BPs)
Number of BPs 
with both systolic 
and diastolic BP 
ending in zero (% 
with both ending 
in zero)
Number of patients 
(% of patients)
Number of BPs (% 
of BPs)
Number of BPs 
with both systolic 
and diastolic BP 
ending in zero (% 
with both ending 
in zero)
  2011 263 691 (37.3) 615 364 (11.2) 125 282 (20.4) 590 921 (37.9) 1 354 956 (10.1) 257 309 (19.0)
  2012 299 590 (42.4) 700 903 (12.7) 128 192 (18.3) 602 642 (38.7) 1 347 042 (10.0) 249 344 (18.5)
  2013 332 809 (47.1) 813 009 (14.8) 133 434 (16.4) 617 073 (39.6) 1 366 085 (10.2) 246 754 (18.1)
  2014 360 180 (50.9) 894 350 (16.3) 137 181 (15.3) 612 382 (39.3) 1 325 141 (9.9) 235 377 (17.8)
  2015 386 541 (54.7) 997 642 (18.1) 153 322 (15.4) 594 589 (38.2) 1 289 040 (9.6) 222 904 (17.3)
*Considering repeated measurements of BP for each patient with respect to measurement year.
BP, blood pressure; BMI, body mass index (weight in kg/height in m2); CPCSSN, Canadian Primary Care Sentinel Surveillance Network; RCGP, Royal 
College of General Practitioners; RSC, Research and Surveillance Centre.
Table 2 Continued 
Table 3 Adjusted ORs of recording zero as the last digit for both systolic and diastolic blood pressure by patient and site 
characteristics
Effect Index group
Reference 
group
Canada UK
OR 95% CI P value OR 95% CI P value
Age (years) 18–39 80+ 1.088 1.063 to 1.112 <0.001 0.784 0.773 to 0.795 <0.001
40–59 80+ 1.012 0.990 to 1.034 0.294 0.788 0.777 to 0.798 <0.001
60–79 80+ 0.942 0.923 to 0.963 <0.001 0.783 0.772 to 0.794 <0.001
Sex Female Male 1.100 1.089 to 1.112 <0.001 1.156 1.148 to 1.163 <0.001
BMI Underweight (BMI<18.5) Obesity class III 
(BMI>40)
1.316 1.267 to 1.366 <0.001 1.047 1.019 to 1.074 0.001
Normal (BMI 18.5–24.9) Obesity class III 1.226 1.192 to 1.258 <0.001 0.960 0.939 to 0.980 <0.001
Overweight (BMI 25–29.9) Obesity class III 1.135 1.104 to 1.166 <0.001 0.947 0.926 to 0.966 <0.001
Obesity class I (BMI 30–34.9) Obesity class III 1.065 1.036 to 1.096 <0.001 0.953 0.932 to 0.973 <0.001
Obesity class II (BMI 
35–39.9)
Obesity class III 1.008 0.978 to 1.040 0.618 0.967 0.943 to 0.992 0.007
Diabetes Yes No 0.982 0.964 to 0.999 0.047 1.025 1.008 to 1.042 0.004
Hypertension Yes No 0.892 0.877 to 0.908 <0.001 0.790 0.780 to 0.799 <0.001
Hypertension 
medications
Yes No 0.967 0.947 to 0.986 0.001 1.057 1.047 to 1.068 <0.001
Practice site size First quartile (smallest site) Fourth quartile 
(largest site)
1.950 1.908 to 1.990 <0.001 0.816 0.809 to 0.823 <0.001
Second quartile Fourth quartile 
(largest site)
1.075 1.058 to 1.094 <0.001 0.893 0.885 to 0.900 <0.001
Third quartile Fourth quartile 
(largest site)
1.087 1.074 to 1.100 <0.001 0.891 0.883 to 0.899 <0.001
Measurement year 2006 2015 1.910 1.833 to 1.990 <0.001 1.647 1.625 to 1.668 <0.001
2007 2015 1.923 1.857 to 1.989 <0.001 1.473 1.451 to 1.494 <0.001
2008 2015 1.840 1.790 to 1.895 <0.001 1.376 1.357 to 1.396 <0.001
2009 2015 1.858 1.815 to 1.903 <0.001 1.321 1.300 to 1.341 <0.001
2010 2015 1.582 1.548 to 1.617 <0.001 1.257 1.238 to 1.275 <0.001
2011 2015 1.379 1.352 to 1.407 <0.001 1.178 1.161 to 1.196 <0.001
2012 2015 1.239 1.216 to 1.262 <0.001 1.112 1.094 to 1.129 <0.001
2013 2015 1.096 1.077 to 1.116 <0.001 1.052 1.038 to 1.067 <0.001
2014 2015 1.037 1.021 to 1.052 <0.001 1.016 1.000 to 1.030 0.041
ORs were adjusted for patient age, sex, presence of hypertension and/or diabetes, BMI, use of hypertensive medications. ORs were also adjusted for the size of 
the practice panels and year of measurement.
BMI, body mass index (weight in kg/height in m2). 
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shown reductions over time, presumably related to the 
progressive introduction of AOBP, although this assump-
tion was not validated.28 In addition, there were changes 
in the patterns of recording odd versus even terminal 
digits. Another study in China also noted decreases in 
EDP over time.29 Implementation of AOBP in offices thus 
appears to be correlated with decreases in EDP.3 7 26
The use of AOBP measurement resulted in lower read-
ings than manual BP measurement (by 5–10 mm Hg) in 
a randomised controlled trial (RCT); AOBP readings 
agreed more closely with the gold standard of 24-hour 
BP measurement than manual BP readings.11 The intro-
duction of AOBP should therefore be associated with a 
combination of lower rates of EDP (greater precision) 
and lower BP readings that are more consistent with the 
gold standard (greater accuracy). An observational study, 
however, found an association between higher rates of 
EDP and lower mean systolic BP, by 2–3 mm Hg.26 A study 
in the UK found that the change from manual to AOBP 
in primary care practices resulted in lower rates of EDP 
but no changes in mean BP.3
We found that sites with low or no EDP (those presum-
ably using AOBP more consistently) had a mean BP that 
was close to 2 mm Hg higher than those with greater 
rates of EDP (and presumably more use of manual BP in 
the practice) rather than the expected 5 mm Hg lower. 
Therefore, observer errors associated with manual BP 
may have resulted in both rounding towards zero and 
systematically rounding down. Rounding down was 
observed for patients with diabetes and hypertension as 
well as for those without these conditions. This could 
potentially lead to underdiagnosis of hypertension and 
undertreatment of diagnosed hypertension. While there 
was no clinically significant association between measure-
ment precision and presence of BP-lowering medication 
(ORs close to 1), our data do not permit us to determine 
Figure 2 Impact of adopting automated office blood pressure machines on end digit preference for systolic blood pressure in 
Toronto.
Figure 3 Proportions of systolic blood pressure (BP) and diastolic BP ending in 1, 3, 7 or 9 per practice site for each year of 
interest in Canada and the UK from 2006 to 2015. EDP, end digit preference.
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whether more precise measurement was associated with 
medication intensification through increase in dosage or 
addition of more medications. This could benefit from 
additional research.
A possible explanation for the observation of rounding 
down is provided by prospect theory, used in behavioural 
economics, which describes decisions made under condi-
tions of uncertainty. Negative perceptions about possible 
risks (or risk aversion) outweigh positive perceptions about 
possible gains.30 There may be a behavioural bias towards 
rounding down; this may avoid perceived risks associated 
with adding more medications with less emphasis on 
gains from cardiovascular outcome prevention.
A large cluster RCT (Cardiovascular Health Awareness 
Program (CHAP)) documented improved management 
of hypertension in communities randomised to the inter-
vention. This consisted of more accurate AOBP-based 
measurement in pharmacies with forwarding of abnormal 
BP results to family physicians.31 The CHAP intervention 
resulted in a significant decrease in hospitalisations due 
to cardiovascular disease (myocardial infarction, stroke, 
heart failure).31 In that trial, there was an improvement 
Table 4 Number and percentage of sites in each EDP group from 2006 to 2015
Year
Canada UK
Low or no EDP Medium EDP High EDP Low or no EDP Medium EDP High EDP
N Percent (%) N Percent (%) N Percent (%) N Percent (%) N Percent (%) N Percent (%)
2006 1 3.6 1 3.6 26 92.9 61 38.4 39 24.5 59 37.1
2007 3 7.3 3 7.3 35 85.4 69 42.9 41 25.5 51 31.7
2008 8 13.8 3 5.2 47 81.0 71 44.1 45 28.0 45 28.0
2009 8 11.1 7 9.7 57 79.2 74 46.0 45 28.0 42 26.1
2010 15 15.3 11 11.2 72 73.5 76 46.6 45 27.6 42 25.8
2011 17 15.5 16 14.5 77 70.0 78 47.9 45 27.6 40 24.5
2012 27 21.8 25 20.2 72 58.1 82 50.3 40 24.5 41 25.2
2013 33 22.8 33 22.8 79 54.5 79 48.5 48 29.4 36 22.1
2014 30 20.0 41 27.3 79 52.7 85 52.1 42 25.8 36 22.1
2015 41 26.5 44 28.4 70 45.2 84 51.2 44 26.8 36 22.0
EDP, end digit preference.
Table 5 Mean sBP by EDP group
CPCSSN database (Canada) RCGP RSC database (UK)
No. of BP 
measurements
Mean sBP in 
mm Hg SD
No. of BP 
measurements
Mean sBP in 
mm Hg SD
All patients Low or no EDP 1 151 795 128.21 18.92 5 618 800 135.05 20.09
High EDP 2 925 279 126.24 18.52 3 624 391 133.29 19.63
Difference 1.97 1.76
Hypertensive Low or no EDP 584 082 134.59 19.29 2 687 218 142.63 19.03
High EDP 1 436 251 133.51 18.36 1 715 006 141.23 18.19
Difference 1.08 1.40
Non-
hypertensive
Low or no EDP 567 713 121.65 16.09 2 931 582 128.10 18.44
High EDP 1 489 028 119.23 15.77 1 909 385 126.15 18.07
Difference 2.42 1.95
Diabetic Low or no EDP 300 630 131.42 18.81 823 959 138.89 18.75
High EDP 675 920 130.52 18.09 515 843 136.76 17.79
Difference 0.9 2.13
Non-diabetic Low or no EDP 851 165 127.08 18.83 4 794 841 134.39 20.23
High EDP 2 249 359 124.96 18.46 3 108 548 132.71 19.86
Difference 2.12 1.68
CPCSSN, Canadian Primary Care Sentinel Surveillance Network; EDP, end digit preference;  RCGP, Royal College of General Practitioners; 
RSC, Research and Surveillance Centre; sBP, systolic blood pressure.
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in BP from a mean of 142 to 123 mm Hg when the initial 
pharmacy-based reading was elevated.32 Systematically, 
more accurate measurement of BP through the use of 
AOBP in the community, followed by notification of the 
primary care provider when BP was elevated, may have 
resulted in more treatment of elevated BP in primary care 
and decreased adverse cardiovascular outcomes.
The results in this real-world observational study in two 
countries are plausibly consistent with those of the CHAP 
RCT. We found that practices with greater precision for 
BP measurement (less EDP) also had a lower prevalence 
of adverse cardiovascular outcomes for their patients. It 
is possible that these practices were using AOBP more 
often and were thus measuring BP with greater accuracy. 
Systematic rounding down associated with higher rates of 
EDP and presumably greater use of manual BP measure-
ment by practices in this study appeared to be associated 
with an elevated frequency of adverse cardiovascular 
outcomes.
A switch to routine use of AOBP for most office-based 
BP measurements would require the purchase of enough 
machines to support the number of physicians and 
patients in each office, training of staff and healthcare 
providers and changes in offices processes to support 
more consistent use of AOBP. We are not aware of finan-
cial or other practice level incentives in either country 
promoting this change.
lIMItAtIOns
The study has several strengths. We used data from routine 
community-based primary care. We also included a large 
sample of both patients and primary care providers from 
multiple settings across Canada and the UK, observed 
over a decade or more. Therefore, this study reasonably 
reflects current clinical practices for individuals receiving 
primary care in both countries.
This study has several shortcomings. This was a conve-
nience sample of primary care practices that contributed 
EMR data to CPCSSN and the RCGP RSC. We surveyed 
Figure 4 Frequency of cardiovascular events in high end digit preference (EDP) and no or low EDP group in the UK.
Table 6 Standardised morbidity ratio for groups with high 
EDP group when compared with groups with low or no EDP
Parameter Estimate 95% CI
Angina 
  Standardised morbidity ratio 1.25 1.22 to 1.28
Acute myocardial infraction
  Standardised morbidity ratio 1.16 1.14 to 1.19
Stroke
  Standardised morbidity ratio 1.15 1.12 to 1.17
EDP, end digit preference.
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practices for their use of AOBP in one network only 
(UTOPIAN); the survey was done at the office level rather 
than by physician. There may be recall bias and the actual 
proportion of patients whose BP was measured using an 
AOBP is unknown.
The study was not randomised; therefore, there may 
be unmeasured confounders associated with both higher 
incidence of cardiovascular outcomes and greater rates of 
EDP. These could include incentives or programmes that 
could lead to improved precision in BP measurement 
along with lower rates in cardiovascular outcomes, such 
as quality standards or funding. Our findings are associa-
tions rather than causation. Nonetheless, the differences 
between groups persisted as practices switched to lower 
rates of EDP over time and there is no a priori reason to 
expect a change in unmeasured confounders in practices 
switching to AOBP and lower rates of EDP.
COnClusIOns
In conclusion, systematic measurement errors including 
rounding down are associated with higher rates of EDP. 
It is likely that this is associated with more manual BP 
measurement in these primary care practices and in turn 
is correlated with a higher risk of adverse cardiovascular 
outcomes at a population level, although we cannot 
infer a causal relationship. Our findings suggest that the 
continued routine use of manual measurement of BP in 
primary care offices may be problematic. We recommend 
the use of AOBP as the standard of care for measuring 
and monitoring BP in medical offices.
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